Vexev, announced the highly successful results of the CANSCAN Trial (NCT06691672), providing evidence that the VxWave ...

The VxWave system’s potential ability to standardize examinations would allow dialysis clinics to better determine subgroups who may be at a disadvantage for vascular access creation, ultimately ...

The VxWave system's potential ability to standardize examinations would allow dialysis clinics to better determine subgroups who may be at a disadvantage for vascular access creation, ultimately ...

As more individuals with T1D develop features of insulin resistance, new tools are needed to identify those at highest risk.

Vexev and U.S. Renal Care today announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system.

The US has a diabetic wound problem. An estimated 1 million patients with diabetes in the US develop a foot ulcer annually.

Vascular risk factors contribute to the burden of cognitive impairment and dementia in the United States, according to a scientific statement from the American Heart Association (AHA) published in ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

Anumana presents new clinical data at AHA 2025, including a late-breaking study and three additional abstracts.

A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may ...

Maryland Innovation Initiative awards more than $2 million across 14 projects COLUMBIA, Md., Nov. 10, 2025 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced the ...

A new study has concluded there is no clear link between Tylenol use during pregnancy and the risk of an offspring developing ...